# ALLANDER BIOTECHNOLOGIES, INC.: cGMP manufacturing the clinical batch of oral gel drug for treating oral mucositis in cancer patients

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | ALLANDER BIOTECHNOLOGIES, INC. |
| Location | AURORA, CO |
| Project | cGMP manufacturing the clinical batch of oral gel drug for treating oral mucositis in cancer patients |
| Project number | 1R44DE034643-01A1 |
| Mechanism | R44 |
| Institute | National Institute of Dental and Craniofacial Research |
| Award | $1,210,798 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-16 to 2028-08-31 |
| UEI | J8KMX54WRJM9 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11321353). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.